icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
7h0Zn2F8a1Jq1TtS